Switch to
More onapp

How to use scorecard? Learn more

Divi's Laboratories Ltd

DIVISLAB
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹97,472 cr, stock is ranked 82
Moderate RiskStock is 2.32x as volatile as Nifty
3,671.7037.20 (-1.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹97,472 cr, stock is ranked 82
Moderate RiskStock is 2.32x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
70.48
PB RatioPB Ratio
7.63
Dividend YieldDiv. Yield
0.82%
Sector PESector PE
51.18
Sector PBSector PB
5.82
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

19%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Brands

Divi's

Pharmaceutical company

Brands

Divi's

Pharmaceutical company

Financial TrendFinancial statements 

20202021202220235.587.039.078.111.381.982.961.82
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnApr 5, 2024

Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Trading Window-XBRL 
Announced OnMar 30, 2024

Divi's Laboratories Limited has informed the Exchange about Closure of Trading Window | Download

Divi's Laboratories Limited has informed the Exchange about Closure of Trading Window | Download

Cash Dividend 
Ex. DateAug 11, 2023

Final • Div/Share: ₹ 30

See all events